Caresyntax vs Harrison.ai

Side-by-side comparison of AI visibility scores, market position, and capabilities

Caresyntax leads in AI visibility (72 vs 54)
Caresyntax logo

Caresyntax

LeaderHealthcare

Surgical Data & Intelligence Platform

Caresyntax is the leading surgical intelligence platform serving 30,000+ surgical professionals across 3,000+ ORs globally; raised $302M total including $180M in 2026 with Symbiotic Capital, BlackRock Innovation Capital, and Optum Ventures.

AI VisibilityBeta
Overall Score
B72
Category Rank
#115 of 596
AI Consensus
75%
Trend
stable
Per Platform
ChatGPT
77
Perplexity
74
Gemini
70

About

Caresyntax is a surgical data and analytics company that captures, integrates, and analyzes multimodal data — including OR video, imaging, device outputs, and clinical records — to improve patient outcomes, surgical performance, and operating room efficiency. The company serves more than 30,000 surgical professionals across more than 3,000 operating rooms globally, with customers spanning hospitals and health systems in the US and EMEA. Its platform provides real-time intraoperative guidance, post-operative performance analytics, risk stratification tools, and resource optimization insights for surgical teams, hospital administrators, and medical device companies.

Full profile
Harrison.ai logo

Harrison.ai

ChallengerHealthcare

AI-Powered Clinical Diagnostics (Radiology & Pathology)

Harrison.ai is an Australian healthcare AI company building clinical-grade AI for radiology and pathology diagnostics; raised $129M+ AUD total at a $400M AUD valuation; its Annalise.ai radiology platform has FDA clearance and processes 5M+ studies;

AI VisibilityBeta
Overall Score
C54
Category Rank
#176 of 596
AI Consensus
85%
Trend
stable
Per Platform
ChatGPT
52
Perplexity
53
Gemini
50

About

Harrison.ai is a Sydney, Australia-based healthcare artificial intelligence company founded in 2018 by brothers Aengus and David Hallinan that builds clinical-grade AI models for diagnostic medicine, initially targeting radiology and pathology. The company''s flagship product — Annalise.ai — is a comprehensive AI platform for radiology interpretation that analyzes chest X-rays, CT scans, and other medical imaging studies to detect and flag a broad range of findings simultaneously. Unlike earlier radiology AI tools designed for single conditions, Annalise.ai is a multi-finding model trained to detect up to 124 findings in a single chest X-ray and 295 findings in chest CTs — providing a comprehensive AI second reader experience rather than a narrow single-disease detector.

Full profile

AI Visibility Head-to-Head

72
Overall Score
54
#115
Category Rank
#176
75
AI Consensus
85
stable
Trend
stable
77
ChatGPT
52
74
Perplexity
53
70
Gemini
50
69
Claude
55
67
Grok
49

Key Details

Category
Surgical Data & Intelligence Platform
AI-Powered Clinical Diagnostics (Radiology & Pathology)
Tier
Leader
Challenger
Entity Type
brand
brand

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.